Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-05-07
Markowitz Wayne Files Edwards Lifesciences (EW) Form 4 - May 07, 2026
Markowitz Wayne traded 6.3K EW shares worth $87.9K in this Form 4 filing, reported to the SEC on 2026-05-07.
- Insider
- Markowitz Wayne
- Issuer
- Edwards Lifesciences Corporation EW · NYSE
- Filed
- Period
- 2026-05-07
- Accession
- 0001225208-26-005132
- Source
- Official filing on sec.gov ↗
Transactions (4)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Markowitz Wayne | 2026-05-11 | Sell | 593 | $79.73 | $47.3K | Direct |
| Markowitz Wayne | 2026-05-08 | Sell | 226 | $82.76 | $18.7K | Direct |
| Markowitz Wayne | 2026-05-07 | Buy | 5.2K | $0.00 | $0.00 | Direct |
| Markowitz Wayne | 2026-05-07 | Sell | 264 | $83.20 | $22.0K | Direct |
| Net change | +4.1K | −$87.9K | ||||
About Edwards Lifesciences Corporation
Edwards Lifesciences Corporation is a leading healthcare company primarily known for its innovative medical devices focused on cardiovascular conditions. The firm's primary function revolves around the development and commercialization of heart valve products and hemodynamic monitoring systems, aimed at enhancing the life quality of patients suffering from cardiovascular diseases. Edwards Lifesciences plays a crucial role in the healthcare sector, particularly impacting the cardiology and surgical fields. Notable for its pioneering work in heart valve therapies, the corporation is at the forefront of transcatheter aortic valve replacement (TAVR) technology, a minimally invasive procedure that offers a significant alternative to traditional open-heart surgeries. Edwards Lifesciences collaborates closely with healthcare professionals to ensure its products address critical medical needs globally. Headquartered in Irvine, California, Edwards Lifesciences operates in a highly competitive and rapidly advancing market, where technological innovation and patient outcomes are pivotal. Its contributions continue to set standards within the medical device industry, reinforcing its market significance by addressing demands for effective cardiovascular care solutions worldwide.
Track EW insider activity
Get alerted when Edwards Lifesciences Corporation executives buy or sell their shares.